Baseline characteristics of patients
| Characteristics . | . | Total = 177 . |
|---|---|---|
| Sex | Male | 108 (61.0) |
| Female | 69 (39.0) | |
| Age (y) | Mean (SD) | 58.1 (9.5) |
| Race | White | 161 (91.0) |
| Black | 10 (5.6) | |
| Native American | 3 (1.7) | |
| Unknown | 3 (1.7) | |
| Ethnicity | Hispanic | 20 (14.9) |
| Non-Hispanic | 106 (79.1) | |
| Unknown | 8 (6.0) | |
| Isotype | IgG | 89 (50) |
| Free light chain | 42 (24) | |
| IgA | 38 (21.5) | |
| IgD | 4 (2.3) | |
| Nonsecretory | 4 (2.3) | |
| GEP | Low | 136 (76.8) |
| High | 37 (20.9) | |
| Unknown/inadequate | 4 (2.2) | |
| ISS | Stage 1 | 72 (40.6) |
| Stage 2 | 73 (41.2) | |
| Stage 3 | 28 (15.7) | |
| Unknown | 4 (2.5) | |
| Albumin | Mean (SD) | 3.4 (0.6) |
| Beta 2 microglobulin | Mean (SD) | 3.6 (2.5) |
| Creatinine | Mean (SD) | 1.1 (0.5) |
| Hemoglobin | Mean (SD) | 10.7 (1.8) |
| Lactate dehydrogenase | Mean (SD) | 189.8 (170.9) |
| GEP cluster | ||
| CD-1 | 25 (14.1%) | |
| CD-2 | 32 (18.1%) | |
| HY | 43 (24.3%) | |
| LB | 13 (7.3%) | |
| MF | 9 (5.1%) | |
| MS | 23 (13.0%) | |
| PR | 27 (15.3%) | |
| Unknown | 5 (2.8%) |
| Characteristics . | . | Total = 177 . |
|---|---|---|
| Sex | Male | 108 (61.0) |
| Female | 69 (39.0) | |
| Age (y) | Mean (SD) | 58.1 (9.5) |
| Race | White | 161 (91.0) |
| Black | 10 (5.6) | |
| Native American | 3 (1.7) | |
| Unknown | 3 (1.7) | |
| Ethnicity | Hispanic | 20 (14.9) |
| Non-Hispanic | 106 (79.1) | |
| Unknown | 8 (6.0) | |
| Isotype | IgG | 89 (50) |
| Free light chain | 42 (24) | |
| IgA | 38 (21.5) | |
| IgD | 4 (2.3) | |
| Nonsecretory | 4 (2.3) | |
| GEP | Low | 136 (76.8) |
| High | 37 (20.9) | |
| Unknown/inadequate | 4 (2.2) | |
| ISS | Stage 1 | 72 (40.6) |
| Stage 2 | 73 (41.2) | |
| Stage 3 | 28 (15.7) | |
| Unknown | 4 (2.5) | |
| Albumin | Mean (SD) | 3.4 (0.6) |
| Beta 2 microglobulin | Mean (SD) | 3.6 (2.5) |
| Creatinine | Mean (SD) | 1.1 (0.5) |
| Hemoglobin | Mean (SD) | 10.7 (1.8) |
| Lactate dehydrogenase | Mean (SD) | 189.8 (170.9) |
| GEP cluster | ||
| CD-1 | 25 (14.1%) | |
| CD-2 | 32 (18.1%) | |
| HY | 43 (24.3%) | |
| LB | 13 (7.3%) | |
| MF | 9 (5.1%) | |
| MS | 23 (13.0%) | |
| PR | 27 (15.3%) | |
| Unknown | 5 (2.8%) |
HY, hyperdiploidy; IgA; immunoglobulin A; IgD; immunoglobulin D; IgG; immunoglobulin G; LB, low bone; PR, proliferation; SD, standard deviation.